BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pacifico L, Andreoli GM, D’Avanzo M, De Mitri D, Pierimarchi P. Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease. World J Gastroenterol 2018; 24(19): 2073-2082 [PMID: 29785076 DOI: 10.3748/wjg.v24.i19.2073]
URL: https://www.wjgnet.com/1007-9327/full/v24/i19/2073.htm
Number Citing Articles
Yan-Li Hao, Zhao-Lian Bian, Lin-Ling Ju, Yuan Liu, Gang Qin. RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary CholangitisDigestive Diseases and Sciences 2020; 65(2): 470 doi: 10.1007/s10620-019-05758-5
Cui Wang, Qing Ma, Xijie Yu. Bile Acid Network and Vascular Calcification-Associated Diseases: Unraveling the Intricate Connections and Therapeutic PotentialClinical Interventions in Aging 2023; : 1749 doi: 10.2147/CIA.S431220
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLDInternational Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
Mitsuhiro Isaka, Ryuji Araki, Hiroshi Ueno, Minoru Okamoto. Intestinal fatty acid-binding protein and osteoprotegerin in anthracycline-induced rabbit models of dilated cardiomyopathyResearch in Veterinary Science 2021; 140: 185 doi: 10.1016/j.rvsc.2021.09.007
Jiayan Cai, Zhenyu Zhang, Jingqi Liu, Xueling Xiao, Chizhen Wang, Manxiang Deng, Luling Chen. Correlation between serum 25‑OH vitamin D expression and non‑alcoholic fatty liver diseaseExperimental and Therapeutic Medicine 2020;  doi: 10.3892/etm.2020.8411
Yadi Li, Yan Yang, Yufang Li, Ping Zhang, Gaiying Ge, Jing Jin, Ting Du, Maiyan Ma, Li Na, Lu Ding, Huiping Sheng. Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosisJournal of International Medical Research 2021; 49(11): 030006052110553 doi: 10.1177/03000605211055378
Niklas Rye Jørgensen, Sarah Seberg Diemar, Gitte Lund Christensen, Nina Kimer, Karen Vagner Danielsen, Søren Møller. Patients With Cirrhosis Have Elevated Bone Turnover but Normal Hepatic Production of OsteoprotegerinThe Journal of Clinical Endocrinology & Metabolism 2022; 107(3): e980 doi: 10.1210/clinem/dgab788
Ahmed E. Noreldin, Islam M. Saadeldin, Norhan E. Khalifa, Asmaa F. Khafaga. Emerging Therapeutic Potential of Short Mitochondrial-produced Peptides for Anabolic OsteogenesisInternational Journal of Peptide Research and Therapeutics 2022; 28(1) doi: 10.1007/s10989-021-10353-2
Reyhaneh Darvish Damavandi, Farzad Shidfar, Mohammad Najafi, Leila Janani, Mohsen Masoodi, Javad Heshmati, Somayeh Ziaei. Effect of portulaca oleracea (purslane) extract on inflammatory factors in nonalcoholic fatty liver disease: A randomized, double-blind clinical trialJournal of Functional Foods 2023; 102: 105465 doi: 10.1016/j.jff.2023.105465
Shaobo Wu, Yao Wu, Lan Lin, Changshun Ruan, Fang Li, Rong Chen, Hongxin Du, Xianxiang Zhang, Xiaohe Luo. Osteoprotegerin deficiency aggravates methionine–choline-deficient diet-induced nonalcoholic steatohepatitis in miceScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-30001-7
Mohsen Nikseresht, Nahid Azarmehr, Arash Arya, Behnam Alipoor, Reza Fadaei, Bahman Khalvati, Hassan Abidi, Amir Hossein Doustimotlagh. Circulating mRNA and plasma levels of osteoprotegerin and receptor activator of NF‐κB ligand in nonalcoholic fatty liver diseaseBiotechnology and Applied Biochemistry 2020;  doi: 10.1002/bab.2047
Laís Cristina Giacobbo, Maria Augusta Andrigo Perin, Thaís Munhoz Pereira, Mariana Oliveira Garmendia, Alexandre Reichow, Ana Cláudia Melo, Bruno Borges de Castilhos, Paula Cristina Trevilatto. RANK/RANKL/OPG gene polymorphisms and loss of orthodontic mini‐implantsOrthodontics & Craniofacial Research 2020; 23(2): 210 doi: 10.1111/ocr.12360
Yuanyuan Zhang, Juyi Li, Yingqun Ni, Yan Wang, Huaizhen Liu. Correlational study on the levels of 25-hydroxyvitamin D and non-alcoholic fatty liver disease in type 2 diabetic patientsBMC Endocrine Disorders 2021; 21(1) doi: 10.1186/s12902-021-00762-1
Doaa El Amrousy, Dalia El-Afify. Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver diseaseCytokine 2020; 135: 155215 doi: 10.1016/j.cyto.2020.155215
Ilias D. Vachliotis, Stergios A. Polyzos. Osteoprotegerin/Receptor Activator of Nuclear Factor-Kappa B Ligand/Receptor Activator of Nuclear Factor-Kappa B Axis in Obesity, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver DiseaseCurrent Obesity Reports 2023; 12(2): 147 doi: 10.1007/s13679-023-00505-4
Samira Zein Sayed, Asmaa Hosni Abd El-Hafez, Mostafa Ahmed Abu El-ela, Mohamed Aboul-fotouh Mourad, Suzan Omar Mousa. OPG/RANK/RANKL axis relation to cardiac iron-overload in children with transfusion-dependent thalassemiaScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-39596-3